Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 7/20 | 0.51 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5880668 | 0.83 | L3MBTL1 (0.45) | — | |
| SCHEMBL7151226 | 0.83 | LGALS8 (0.64) | LGALS8SLC5A1LGALS3 | |
| SCHEMBL7153013 | 0.83 | LGALS8 (0.64) | LGALS8SLC5A1LGALS3 | |
| SCHEMBL20371001 | 0.83 | LGALS8 (0.64) | LGALS8SLC5A1LGALS3 | |
| SCHEMBL14601942 | 0.83 | LGALS8 (0.64) | LGALS8SLC5A1LGALS3 | |
| SCHEMBL14783443 | 0.83 | L3MBTL1 (0.45) | — | |
| SCHEMBL7150008 | 0.83 | LGALS8 (0.64) | LGALS8SLC5A1LGALS3 | |
| SCHEMBL15119995 | 0.83 | LGALS8 (0.64) | LGALS8SLC5A1LGALS3 | |
| SCHEMBL7147929 | 0.83 | LGALS8 (0.64) | LGALS8SLC5A1LGALS3 | |
| SCHEMBL1521238 | 0.81 | L3MBTL1 (0.47) | LGALS8LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110104189-A1 | COMPOSITIONS OBTAINED FROM CHLORELLA EXTRACT HAVING IMMUNOMODULATING PROPERTIES | OCEAN NUTRITION CANADA LIMITED (CA) | 2011-05-05 | — | — | US | disclosed |
| EP-2300026-A2 | COMPOSITIONS OBTAINED FROM CHLORELLA EXTRACT HAVING IMMUNOMODULATING PROPERTIES | Ocean Nutrition Canada Limited (CA) | 2011-03-30 | — | — | EP | disclosed |
| WO-2009136296-A2 | COMPOSITIONS OBTAINED FROM CHLORELLA EXTRACT HAVING IMMUNOMODULATING PROPERTIES | OCEAN NUTRITION CANADA LIMITED (CA) | 2009-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104189-A1 | COMPOSITIONS OBTAINED FROM CHLORELLA EXTRACT HAVING IMMUNOMODULATING PROPERTIES | CD58, ALG1, C5 | LGALS8 429/4885SLC5A1 4616/4885LGALS3 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.